ReviewInternal medicine (Tokyo, Japan)2021

Osimertinib for Lung Squamous Cell Carcinoma: A Case Report and Literature Review.

Yuki Yoshimatsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.